Effects Of New Drugs On Overall Health Spending: Frank Lichtenberg Responds
Open Access
- 1 May 2007
- journal article
- comment
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 26 (3), 887-890
- https://doi.org/10.1377/hlthaff.26.3.887
Abstract
When the model I estimated in 2002 is modified in all of the ways advocated by Yuting Zhang and Stephen Soumerai, it still implies that in general, using newer drugs reduces nondrug costs more than it increases drug costs. Moreover, some of Zhang and Soumerai’s modifications might be inappropriate, and they did not make a necessary adjustment that implies that the true cost offset is considerably larger than their estimate. Their description of my methodology is quite inaccurate, and they ignored some previous evidence of large cost offsets based on an entirely different methodology (analysis of longitudinal group-level data) not subject to their critique.Keywords
This publication has 4 references indexed in Scilit:
- Do Newer Prescription Drugs Pay For Themselves? A Reassessment Of The EvidenceHealth Affairs, 2007
- The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003PharmacoEconomics, 2006
- New Cardiovascular Drugs: Patterns of Use and Association with Non-Drug Health ExpendituresINQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2005
- Availability of New Drugs and Americans??? Ability to WorkJournal of Occupational and Environmental Medicine, 2005